Summit Financial’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.13M Buy
48,168
+7,506
+18% +$1.28M 0.1% 197
2025
Q4
$6.86M Buy
40,662
+22,507
+124% +$3.66M 0.1% 195
2025
Q3
$2.62M Buy
18,155
+8,355
+85% +$1.14M 0.04% 412
2025
Q2
$1.24M Buy
9,800
+5,164
+111% +$634K 0.03% 371
2025
Q1
$593K Sell
4,636
-1,036
-18% -$140K 0.02% 474
2024
Q4
$750K Sell
5,672
-1,056
-16% -$148K 0.03% 372
2024
Q3
$980K Buy
6,728
+382
+6% +$55.3K 0.04% 264
2024
Q2
$871K Buy
6,346
+614
+11% +$82K 0.04% 253
2024
Q1
$787K Buy
+5,732
New +$783K 0.05% 214
2022
Q4
Sell
-3,191
Closed -$373K 257
2022
Q3
$373K Buy
3,191
+15
+0.5% +$1.86K 0.04% 195
2022
Q2
$374K Buy
+3,176
New +$377K 0.04% 178

Other funds holding IBB